294 related articles for article (PubMed ID: 37234978)
1. Recent advances in understanding DNA methylation of prostate cancer.
Shin HJ; Hua JT; Li H
Front Oncol; 2023; 13():1182727. PubMed ID: 37234978
[TBL] [Abstract][Full Text] [Related]
2. Aberrant CpG island hypermethylation of multiple genes in prostate cancer and prostatic intraepithelial neoplasia.
Kang GH; Lee S; Lee HJ; Hwang KS
J Pathol; 2004 Feb; 202(2):233-40. PubMed ID: 14743506
[TBL] [Abstract][Full Text] [Related]
3. Aberrant TET1 Methylation Closely Associated with CpG Island Methylator Phenotype in Colorectal Cancer.
Ichimura N; Shinjo K; An B; Shimizu Y; Yamao K; Ohka F; Katsushima K; Hatanaka A; Tojo M; Yamamoto E; Suzuki H; Ueda M; Kondo Y
Cancer Prev Res (Phila); 2015 Aug; 8(8):702-11. PubMed ID: 26063725
[TBL] [Abstract][Full Text] [Related]
4. Genome-scale analysis of aberrant DNA methylation in colorectal cancer.
Hinoue T; Weisenberger DJ; Lange CP; Shen H; Byun HM; Van Den Berg D; Malik S; Pan F; Noushmehr H; van Dijk CM; Tollenaar RA; Laird PW
Genome Res; 2012 Feb; 22(2):271-82. PubMed ID: 21659424
[TBL] [Abstract][Full Text] [Related]
5. Noninvasive Detection of Neuroendocrine Prostate Cancer through Targeted Cell-free DNA Methylation.
Franceschini GM; Quaini O; Mizuno K; Orlando F; Ciani Y; Ku SY; Sigouros M; Rothmann E; Alonso A; Benelli M; Nardella C; Auh J; Freeman D; Hanratty B; Adil M; Elemento O; Tagawa ST; Feng FY; Caffo O; Buttigliero C; Basso U; Nelson PS; Corey E; Haffner MC; Attard G; Aparicio A; Demichelis F; Beltran H
Cancer Discov; 2024 Mar; 14(3):424-445. PubMed ID: 38197680
[TBL] [Abstract][Full Text] [Related]
6. Circulating tumor DNA profile recognizes transformation to castration-resistant neuroendocrine prostate cancer.
Beltran H; Romanel A; Conteduca V; Casiraghi N; Sigouros M; Franceschini GM; Orlando F; Fedrizzi T; Ku SY; Dann E; Alonso A; Mosquera JM; Sboner A; Xiang J; Elemento O; Nanus DM; Tagawa ST; Benelli M; Demichelis F
J Clin Invest; 2020 Apr; 130(4):1653-1668. PubMed ID: 32091413
[TBL] [Abstract][Full Text] [Related]
7. Pan-cancer stratification of solid human epithelial tumors and cancer cell lines reveals commonalities and tissue-specific features of the CpG island methylator phenotype.
Sánchez-Vega F; Gotea V; Margolin G; Elnitski L
Epigenetics Chromatin; 2015; 8():14. PubMed ID: 25960768
[TBL] [Abstract][Full Text] [Related]
8. CpG island hypermethylator phenotype in gastric carcinoma and its clinicopathological features.
Park SY; Kook MC; Kim YW; Cho NY; Jung N; Kwon HJ; Kim TY; Kang GH
Virchows Arch; 2010 Oct; 457(4):415-22. PubMed ID: 20737169
[TBL] [Abstract][Full Text] [Related]
9. The expanding role of epigenetics in the development, diagnosis and treatment of prostate cancer and benign prostatic hyperplasia.
Dobosy JR; Roberts JL; Fu VX; Jarrard DF
J Urol; 2007 Mar; 177(3):822-31. PubMed ID: 17296351
[TBL] [Abstract][Full Text] [Related]
10. Integrative Genome-Scale DNA Methylation Analysis of a Large and Unselected Cohort Reveals 5 Distinct Subtypes of Colorectal Adenocarcinomas.
Fennell L; Dumenil T; Wockner L; Hartel G; Nones K; Bond C; Borowsky J; Liu C; McKeone D; Bowdler L; Montgomery G; Klein K; Hoffmann I; Patch AM; Kazakoff S; Pearson J; Waddell N; Wirapati P; Lochhead P; Imamura Y; Ogino S; Shao R; Tejpar S; Leggett B; Whitehall V
Cell Mol Gastroenterol Hepatol; 2019; 8(2):269-290. PubMed ID: 30954552
[TBL] [Abstract][Full Text] [Related]
11. Genome-wide methylation analysis identifies a core set of hypermethylated genes in CIMP-H colorectal cancer.
McInnes T; Zou D; Rao DS; Munro FM; Phillips VL; McCall JL; Black MA; Reeve AE; Guilford PJ
BMC Cancer; 2017 Mar; 17(1):228. PubMed ID: 28351398
[TBL] [Abstract][Full Text] [Related]
12. Aberrant methylation in gastric cancer associated with the CpG island methylator phenotype.
Toyota M; Ahuja N; Suzuki H; Itoh F; Ohe-Toyota M; Imai K; Baylin SB; Issa JP
Cancer Res; 1999 Nov; 59(21):5438-42. PubMed ID: 10554013
[TBL] [Abstract][Full Text] [Related]
13. Hypermethylation of CpG island loci and hypomethylation of LINE-1 and Alu repeats in prostate adenocarcinoma and their relationship to clinicopathological features.
Cho NY; Kim BH; Choi M; Yoo EJ; Moon KC; Cho YM; Kim D; Kang GH
J Pathol; 2007 Feb; 211(3):269-77. PubMed ID: 17139617
[TBL] [Abstract][Full Text] [Related]
14. Characterization of the CpG island methylator phenotype subclass in papillary thyroid carcinoma.
Gu P; Zeng Y; Ma W; Zhang W; Liu Y; Guo F; Ruan X; Chi J; Zheng X; Gao M
Front Endocrinol (Lausanne); 2022; 13():1008301. PubMed ID: 36353231
[TBL] [Abstract][Full Text] [Related]
15. DNA methylation instability by BRAF-mediated TET silencing and lifestyle-exposure divides colon cancer pathways.
Noreen F; Küng T; Tornillo L; Parker H; Silva M; Weis S; Marra G; Rad R; Truninger K; Schär P
Clin Epigenetics; 2019 Dec; 11(1):196. PubMed ID: 31842975
[TBL] [Abstract][Full Text] [Related]
16. Epigenetic profiling of synchronous colorectal neoplasias by quantitative DNA methylation analysis.
Ogino S; Brahmandam M; Kawasaki T; Kirkner GJ; Loda M; Fuchs CS
Mod Pathol; 2006 Aug; 19(8):1083-90. PubMed ID: 16699497
[TBL] [Abstract][Full Text] [Related]
17. Hypermethylation of CpG islands in primary and metastatic human prostate cancer.
Yegnasubramanian S; Kowalski J; Gonzalgo ML; Zahurak M; Piantadosi S; Walsh PC; Bova GS; De Marzo AM; Isaacs WB; Nelson WG
Cancer Res; 2004 Mar; 64(6):1975-86. PubMed ID: 15026333
[TBL] [Abstract][Full Text] [Related]
18. Aberrant Promoter Methylation of Protocadherin8 (PCDH8) in Serum is a Potential Prognostic Marker for Low Gleason Score Prostate Cancer.
Lin YL; Li YL; Ma JG
Med Sci Monit; 2017 Oct; 23():4895-4900. PubMed ID: 29026066
[TBL] [Abstract][Full Text] [Related]
19. Genome-wide DNA methylation sequencing reveals miR-663a is a novel epimutation candidate in CIMP-high endometrial cancer.
Yanokura M; Banno K; Adachi M; Aoki D; Abe K
Int J Oncol; 2017 Jun; 50(6):1934-1946. PubMed ID: 28440489
[TBL] [Abstract][Full Text] [Related]
20. DNMT3b overexpression contributes to a hypermethylator phenotype in human breast cancer cell lines.
Roll JD; Rivenbark AG; Jones WD; Coleman WB
Mol Cancer; 2008 Jan; 7():15. PubMed ID: 18221536
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
